Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
17 pending office actions • 1 client • 17 examiners • 11 art units • 0 of 17 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (6%) |
| §103 only | 4 (24%) |
| §112 only | 2 (12%) |
| Double-patenting only | 1 (6%) |
| Double-patenting + other | 4 (24%) |
| Multi-statute (no §101) | 5 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
| SCHUBERG, LAURA J | 1 | 23.6% | +37.0% |
| TAKENAKA, RISA | 1 | 27.3% | +100.0% |
| LARA, CAROLINE MONSERRAT | 1 | 100.0% | +0.0% |
| GONZALES, JOSEPHINE MARIA | 1 | 26.6% | +38.4% |
| WEHBE, ANNE MARIE SABRINA | 1 | 57.2% | +43.4% |
| CANELLA, KAREN A | 1 | 62.2% | +32.8% |
| STOICA, ELLY GERALD | 1 | 66.9% | +22.5% |
| MELCHIOR, JAMES RYLAND | 1 | 63.0% | +38.5% |
| PHILIPOSE, HANNAH SARAH | 1 | 0.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18440260 | EFFICIENT DIFFERENTIATION OF SECOND HEART FIELD CARDIAC PROGENITOR CELLS AND RIGHT VENTRICLE CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | LARA, CAROLINE MONSERRAT | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17820488 | RETINAL ORGANOID MODEL SYSTEMS | HOLLAND, PAUL J | 73d overdue |
| 17352873 | PLURIPOTENT STEM CELLS OBTAINED BY NON-VIRAL REPORGRAMMING | WILSON, MICHAEL C | 33d |
| 18302636 | COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS | MELCHIOR, JAMES RYLAND | 84d |
| 18829184 | Methods for In Vivo Tracking of Cells | MOSHER, ERIC PARKER | — |
| 18819158 | Generating Vasculogenic Cell Populations | SCHUBERG, LAURA J | — |
| 18613041 | REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION | TAKENAKA, RISA | — |
| 18451617 | GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS | GONZALES, JOSEPHINE MARIA | — |
| 18165244 | SIRPalpha Inhibited Macrophages and Neutrophils and Uses Thereof | PHILIPOSE, HANNAH SARAH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18302636 | COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS | MELCHIOR, JAMES RYLAND | 84d |
| 18819158 | Generating Vasculogenic Cell Populations | SCHUBERG, LAURA J | — |
| 18613041 | REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION | TAKENAKA, RISA | — |
| 18451617 | GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS | GONZALES, JOSEPHINE MARIA | — |
| 18351246 | Macrophage Cell Therapy to Treat Orthopedic Injury | WEHBE, ANNE MARIE SABRINA | — |
| 18345385 | Targeted Radiotherapy Chelates for In Situ Immune Modulated Cancer Vaccination | CANELLA, KAREN A | — |
| 18332457 | Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity | STOICA, ELLY GERALD | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Wisconsin Alumni Research Foundation | 17 |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1653 | 2 |
| 1633 | 2 |
| 1634 | 1 |
| 1643 | 1 |
| 1618 | 1 |
| 1644 | 1 |
| 1675 | 1 |
| 1656 | 1 |
| 1632 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18829184 | Methods for In Vivo Tracking of Cells | Wisconsin Alumni Research Foundation | MOSHER, ERIC PARKER | §103§112 | Non-Final OA | — | Pending | Sep 09, 2024 | |
| 18819158 | Generating Vasculogenic Cell Populations | Wisconsin Alumni Research Foundation | SCHUBERG, LAURA J | §103§112DP | Non-Final OA | — | Pending | Aug 29, 2024 | |
| 18613041 | REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION | Wisconsin Alumni Research Foundation | TAKENAKA, RISA | 1653 | §102§103§112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18440260 | EFFICIENT DIFFERENTIATION OF SECOND HEART FIELD CARDIAC PROGENITOR CELLS AND RIGHT VENTRICLE CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | Wisconsin Alumni Research Foundation | LARA, CAROLINE MONSERRAT | 1633 | §102§112DP | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18451617 | GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS | Wisconsin Alumni Research Foundation | GONZALES, JOSEPHINE MARIA | 1631 | §103 | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18351246 | Macrophage Cell Therapy to Treat Orthopedic Injury | Wisconsin Alumni Research Foundation | WEHBE, ANNE MARIE SABRINA | 1634 | §112 | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18345385 | Targeted Radiotherapy Chelates for In Situ Immune Modulated Cancer Vaccination | Wisconsin Alumni Research Foundation | CANELLA, KAREN A | 1643 | DP | Non-Final OA | — | Pending | Jun 30, 2023 |
| 18332457 | Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity | Wisconsin Alumni Research Foundation | STOICA, ELLY GERALD | 1618 | §103§112DP | Non-Final OA | — | Pending | Jun 09, 2023 |
| 18302636 | COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS | Wisconsin Alumni Research Foundation | MELCHIOR, JAMES RYLAND | 1644 | §103§112 | Non-Final OA | 84d | Pending | Apr 18, 2023 |
| 18165244 | SIRPalpha Inhibited Macrophages and Neutrophils and Uses Thereof | Wisconsin Alumni Research Foundation | PHILIPOSE, HANNAH SARAH | 1631 | §103§112 | Non-Final OA | — | Pending | Feb 06, 2023 |
| 17973020 | Simplified Compositions and Methods for Generating Neural Stem Cells from Human Pluripotent Stem Cells | Wisconsin Alumni Research Foundation | DUTT, ADITI | 1675 | §112DP | Non-Final OA | — | Pending | Oct 25, 2022 |
| 17820488 | RETINAL ORGANOID MODEL SYSTEMS | Wisconsin Alumni Research Foundation | HOLLAND, PAUL J | 1656 | §101§103 | Final Rejection | 73d overdue | Pending | Aug 17, 2022 |
| 17863363 | LPS Priming of Stromal Cells to Generate LPS-Specific Exosome Educated Macrophages | Wisconsin Alumni Research Foundation | FOX, ALLISON M | 1633 | §112Other | Final Rejection | 37d overdue | Pending | Jul 12, 2022 |
| 17545416 | METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES | Wisconsin Alumni Research Foundation | STAVROU, CONSTANTINA E | 1632 | §103 | Non-Final OA | — | Pending | Dec 08, 2021 |
| 17352873 | PLURIPOTENT STEM CELLS OBTAINED BY NON-VIRAL REPORGRAMMING | Wisconsin Alumni Resarch Foundation | WILSON, MICHAEL C | 1638 | §103§112 | Non-Final OA | 33d | Pending | Jun 21, 2021 |
| 17343647 | COMPOSITIONS AND METHODS FOR PRECISE PATTERNING OF POSTERIOR NEUROECTODERM FROM HUMAN PLURIPOTENT STEM CELLS | Wisconsin Alumni Research Foundation | WILLIAMS, EMMALEE RAE | 1653 | §103 | Final Rejection | — | Pending | Jun 09, 2021 |
| 17117062 | IN VITRO EXPANSION OF DOPAMINERGIC SUBTYPE NEURONAL PROGENITORS DERIVED FROM PLURIPOTENT STEM CELLS | Wisconsin Alumni Research Foundation | MIANO, JOSEPH PAUL | 1631 | §103 | Non-Final OA | — | Pending | Dec 09, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial